Диссертация (1146661), страница 18
Текст из файла (страница 18)
The urea reduction ratio and serumalbumin concentrations as predictors of mortality in patients undergoinghemodialysis // N. Eng. J. Med.–1993.–Vol. 329, № 14.–P. 1001-1006.159. Owen W.F., Lowrie E.G. C-reactive protein as an outcome predictor formaintenance hemodialysis patients // Kidney Int.–1998.–Vol. 54.–P. 627-636.160. Panzetta G. Protein intake does not depend on the dose of dialysis delivered-provided Kt/V is adequate.// Nephrol Dial Transplant.
1995 Dec;10(12): Р.22869.161. Parker T.F., Laird N.M., Lowrie E.G. Comparison of the study groups in theNational Cooperative Dialysis Study and a description of morbidity, mortality,and patient withdrawal // Kidney Int.–1983.–Vol. 23, Suppl. 13.–P. 42-49.162. Pollock C.A., Allen B.J., Warden R.A. et al. Total - body nitrogen by neutronactivation in maintenance dialysis // Am. J.
Nephrol.–1990.–Vol. 19, № 1.–P. 3845.163. Pollock C.A., Ibels L.S., Ayass W. et al. Total body nitrogen as a prognosticmarker maintemence dialysis // J. Am. Soc. Nephrol.–1995.–Vol. 16.–P. 82-88.164. Popovic V. Ghrelin // Current Opinion in Endocrinology @ diabetes 2006; 13:Р.70- 75.165.Pressman M.R., Benz R.L. Sleep disordered breathing in ESRD: acutebeneficial effects of treatment with nasal continuous positive airway pressure //Kidney Int.–1993.–Vol. 43, № 5.–P. 1134-1139.125166. Pupim L. B., Ikizler T.
A. Uremic Malnutrition: New Insights Into an OldProblem: Review // Seminars in Dialysis (Cambridge, Ma).–2003.–Vol.16, №3.–P. 224-232.167. Rahmati M.A., Craig R.G., Homel P., Kaysen G.A., Levin N.W. Serummarkers of periodontal disease status and inflammation in hemodialysis patients//Am J Kidney Dis. 2002 Nov;40(5): Р.983-9.168. Rasmi Y., Farshid S., Makhdomi K. Effect of duration on hemodialysis onprevalence of Helicobacter pylori infection// Saudi J Kidney Dis Transpl. 2012May;23(3): Р. 489-92.169. Reaich D., Channon S.M., Scrimgeour C.M.
et al. Correction of acidosis inhumans with CRF decreases protein degradation and amino acid oxidation // Am.J. Physiol.–1993.–Vol. 265.–P. 230-235.170. Rocco A., Fiorillo M. Helicobarter pylory infection in dyspeptic patients withand without chronic renal failure // Helicobacter 2005; 10 (1): Р. 53-58.171. Ross R., Després J.P. Abdominal obesity, insulin resistance, and the metabolicsyndrome: contribution of physical activity/exercise// Obesity (Silver Spring).2009 Dec;17 Suppl 3: Р.S1-2.172.
Rosman J.B., Brandl M., Langer K. Amino acid profiles during prolongeddietary protein restriction // Contrib. Nephrol.–1990.–Vol. 81.–P. 188-193173. Sanaka T., Shinole M., Audo M. et al. IGF-1 as an early indicator malnutritionin patients with end-stage renal disease // Nephron.–1994.–Vol.
67, № 1.–P. 7381.174. Sardesai V.M. Fundamentals of nutrition // In: Dekker M (ed) / Introductionto Clinical Nutrition. New York: Sardesai.–1998.–P. 1-13.175. Sargent J.A., Gotch F.A. Mathematic modeling of dialysis therapy // KidneyInt.–1980.–Vol. 18, № 10.–P. 2-10.126176. Schaefer F., Chen Y., Tsao T. et al. Impaired JAK-STAT signal transductioncontributes to growth hormone resistance in chronic uremia // J. Clin. Invest.–2001.–Vol. 108.–P.
467-475.177. Schmidt A., Fabrizii V., Maier C. et al . Normal regulation of elevated plasmaghrelin concentrations in dialysis patients // Wien Klin Wochenschr. 2004 Apr30;116(7-8): Р.235-9.178. Schofield C., Ashworth A. Why have mortality rates for severe malnutritionremained so high ? // Bull. World Health Organ.–1996.–Vol. 74, № 2.–P. 223229.179.
Scholze A., Tepel M. Role of leptin in reverse epidemiology in chronic kidneydisease// Semin Dial. 2007 Nov-Dec;20(6): Р.534-8.180. Simonian H.P., Kresge K.M., Boden G.H., Parkman H.P. Differential effectsof sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels:evidence for vagal efferents stimulation mediating ghrelin release //Neorogastroenterol Motil 2005; 17: Р. 348-354.181.
Suneja M., Murry D.J., Stokes J.B., Lim V.S. Hormonal regulation of energyprotein homeostasis in hemodialysis patients: an anorexigenic profile that maypredispose to adverse cardiovascular outcomes// Am J Physiol EndocrinolMetab. 2011 Jan;300(1): Р. E55-64.182. Stenvinkel P., Heimburger O., Paultre F.
et al. Strong association betweenmalnutrition, inflammation, and atherosclerosis in chronic renal failure // KidneyInt.–1999.–Vol. 55.–P. 1899-1911.183. Stenvinkel P., Heimburger O., Lindholm B. et al. Are there two types ofmalnutrition in chronic renal failure? Evidence for relationships betweenmalnutrition, inflammation, and atherosclerosis (MIA syndrome) // Nephrol.Dial. Transplant.–2000.–Vol. 15, № 7.–P. 953-960.127184.
Suhardjono, Malnutrition-inflammation syndrome in a hemodialysispopulation: the influence of polymorphic IL-6-174 and IL-10-1082 genes// ActaMed Indones. 2006 Jul-Sep;38(3): Р.145-9.185. Taylor M.S., Hwang Y., Hsiao P.Y. Ghrelin O-acyltransferase assays andinhibition// Methods Enzymol. 2012;514: Р.205-28.186. The European Helicobacter pylori Study Group (1997) Current Europeanconcepts in the management of Helicobacter pylori infection: The MaastrichtConsensus Report. Gut, 41: Р.8–13.187. Tong J., Prigeon R.L., Davis H.W.
et. al. Physiologic concentrations ofexogenously infused ghrelin reduces insulin secretion without affecting insulinsensitivity in healthy humans // J Clin Endocrinol Metab. 2013 Jun;98(6): Р.2536-43.188. Torun B., Chew F. Protein – energy malnutrition // Modern nutrition in Healthand Disease. (8th ed.) / Shils M. E., Olson J. A., Shike M. – Williams andWilkins.–1994.–P. 950-976.189. Uribarri J., Protein catabolic rate may underestimate dietary protein intake inhemodialysis patients// Nephron.
1999 Jun;82(2): Р.97-9.190. Yang Y.J., Sheu B.S., Yang H.B., Lu C.C., Chuang C.C. Eradication ofHelicobacter pylori increases childhood growth and serum acylated ghrelin levels// World J Gastroenterol. 2012 Jun 7;18(21):Р.2674-81.191. Yao Q., Lindholm B., Stenvinkel P. Inflammation as a cause of malnutrition,atherosclerotic cardiovascular disease, and poor outcome in hemodialysispatients // Hemodialysis Int.–2004.–Vol.
8, № 2.–P. 118-129.192. Young G.A., Swanepoel C.R., Croft M.R. et al. Anthropometry and plasmavaline, amimo acids, and proteins in the nutritional assessment of hemodialysispatients // Kidney Int.–1982.–Vol. 21, № 3.–P. 492-499.128193. Yoshimoto A., Mori K., Sugawara A. Plasma ghrelin and desacyl ghrelinconcentrations in renal failure//J Am Soc Nephrol. 2002 Nov;13(11):Р.2748-52.194. van der Lely A.J., Tschop M., Heiman M., Ghigo E.
Biologycal,physiological, pathophysiological and pharmacological aspects of ghrelin //Endocr Rev 2004; 25:Р. 426-457.195. Var C., Gültekin F., Candan F. et al. The effects of hemodialysis on duodenaland gastric mucosal changes in uremic patients// Clin Nephrol. 1996May;45(5):Р.310-4.196. Verdery R.B., Goldberg A.P. Hypocholesterolemia as a predictor of death: Aprospective study of 224 nursing home residents // J. Gerontol.–1991.–Vol.
46,№ 3.–P. М84-М90.197. Walser M. Dialysis and protein malnutrition // Kidney Int.–1999.–Vol.56, №1.–P. 353.198. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation tothe metabolic syndrome // Endocr. Rev.–2000.–Vol. 21.–P. 697-738.199. Wang L., Stengel A., Goebel-Stengel M., Shaikh A., Yuan P.Q., Taché Y.Intravenous injection of urocortin 1 induces a CRF2 mediated increase incirculating ghrelin and glucose levels through distinct mechanisms in rats//Peptides. 2013 Jan;39: Р.164-70.200.
Wee A., Kang J.Y., Ho M.S. et al., Gastroduodenal mucosa in uraemia:endoscopic and histological correlation and prevalence of helicobacter-likeorganisms// Gut. 1990 Oct;31(10):Р.1093-6.201.Wittert G., Chapman I. Physiology of gut hormones an overview // CurrentOpinion in Endocrinology and Diabetes (Hagerstown, Md) 2006; 13 (1): Р.3641.129202. Wolfson M., Strong C.J., Minturn D. et al. Nutritional status and limphocytefunction in maintenance hemodialysis patients // Am. J.
Clin Nutr.–1984.–Vol.37, № 4.–P. 547 – 555.203. Zizzari P., Halem H., Taylor J. et al. Endogenous ghrelin regulates episodicGH secretion by amplifying GH pulse amplitude evidence from antagonism ofthe GHS-R1a receptor // Endocrinology 2005; 146: Р.3836-3842.130.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
